Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda J Hooper

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Expert Opinion on Pharmacotherapy|September 21, 2024
Olezarsen, a liver-directed <i>APOC3</i> ASO therapy for hypertriglyceridemiaAmanda J Hooper, Damon A Bell, John R Burnett
Expert Opinion on Investigational Drugs|November 10, 2025
Assessing the clinical progress of muvalaplin for reducing lipoprotein(a)Amanda J Hooper, P Mihika S Fernando, John R Burnett
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 12, 2008
Familial hypobetalipoproteinemia in a Turkish family with hereditary spastic paraplegiaAmanda J Hooper, Baris Akinci, Abdurrahman Comlekci, et al.
Expert Opinion on Investigational Drugs|January 8, 2024
Potential of muvalaplin as a lipoprotein(a) inhibitorAmanda J Hooper, P Mihika S Fernando, John R Burnett
Expert Opinion on Investigational Drugs|May 3, 2024
Lepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular diseaseP Mihika S Fernando, Amanda J Hooper, John R Burnett
Critical Reviews in Clinical Laboratory Sciences|January 5, 2006
Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolismAmanda J Hooper, Frank M van Bockxmeer, John R Burnett
Annals of Clinical Biochemistry|March 5, 2014
Clinical features and genetic analysis of three patients with severe hypertriglyceridaemiaAmanda J Hooper, Jagadeesh Kurtkoti, Ian Hamilton-Craig, et al.
Annals of Clinical Biochemistry|March 20, 2014
A novel missense SMPD1 gene mutation, T460P, and clinical findings in a patient with Niemann-Pick disease type B presenting to a lipid disorders clinicYael Grasko, Amanda J Hooper, John R Burnett, et al.
Pathology|May 29, 2021
l-asparaginase-induced biochemical toxicities in young adults with acute lymphoblastic leukaemia and T-lymphoblastic lymphomaJessica M Heenan, Amanda J Hooper, John R Burnett, et al.
BMJ Case Reports|April 8, 2017
Isolated brachydactyly type E and idiopathic pancreatitis in a patient presenting to a lipid disorders clinicMichael M Page, Amanda J Hooper, Paul Glendenning, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Expert Opinion on Pharmacotherapy|September 21, 2024
Olezarsen, a liver-directed <i>APOC3</i> ASO therapy for hypertriglyceridemiaAmanda J Hooper, Damon A Bell, John R Burnett
Expert Opinion on Investigational Drugs|November 10, 2025
Assessing the clinical progress of muvalaplin for reducing lipoprotein(a)Amanda J Hooper, P Mihika S Fernando, John R Burnett
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 12, 2008
Familial hypobetalipoproteinemia in a Turkish family with hereditary spastic paraplegiaAmanda J Hooper, Baris Akinci, Abdurrahman Comlekci, et al.
Expert Opinion on Investigational Drugs|January 8, 2024
Potential of muvalaplin as a lipoprotein(a) inhibitorAmanda J Hooper, P Mihika S Fernando, John R Burnett
Expert Opinion on Investigational Drugs|May 3, 2024
Lepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular diseaseP Mihika S Fernando, Amanda J Hooper, John R Burnett
Critical Reviews in Clinical Laboratory Sciences|January 5, 2006
Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolismAmanda J Hooper, Frank M van Bockxmeer, John R Burnett
Annals of Clinical Biochemistry|March 5, 2014
Clinical features and genetic analysis of three patients with severe hypertriglyceridaemiaAmanda J Hooper, Jagadeesh Kurtkoti, Ian Hamilton-Craig, et al.
Annals of Clinical Biochemistry|March 20, 2014
A novel missense SMPD1 gene mutation, T460P, and clinical findings in a patient with Niemann-Pick disease type B presenting to a lipid disorders clinicYael Grasko, Amanda J Hooper, John R Burnett, et al.
Pathology|May 29, 2021
l-asparaginase-induced biochemical toxicities in young adults with acute lymphoblastic leukaemia and T-lymphoblastic lymphomaJessica M Heenan, Amanda J Hooper, John R Burnett, et al.
BMJ Case Reports|April 8, 2017
Isolated brachydactyly type E and idiopathic pancreatitis in a patient presenting to a lipid disorders clinicMichael M Page, Amanda J Hooper, Paul Glendenning, et al.
Pageof 13